Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.51 |
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 4/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.37 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.33 |
| ▸ | STAT3 | P40763 | 1/20 | 0.33 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.33 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.33 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.33 |
| ▸ | CDK9 | P50750 | 1/20 | 0.33 |
| ▸ | TAS2R46 | P59540 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31601392 | 0.90 | LMNA (0.51) | LMNATSHRALDH1A1NPC1RAB9A | |
| SCHEMBL17616822 | 0.90 | LMNA (0.51) | LMNATSHRALDH1A1NPC1RAB9A | |
| SCHEMBL2431486 | 0.90 | LMNA (0.51) | LMNATSHRALDH1A1NPC1RAB9A | |
| SCHEMBL19189795 | 0.87 | LMNA (0.43) | LMNATSHRALDH1A1ALOX15MAPK1 | |
| SCHEMBL5950833 | 0.84 | TSHR (0.56) | LMNATSHRALDH1A1NPC1RAB9A | |
| SCHEMBL4322994 | 0.84 | LMNA (0.46) | LMNATSHRALDH1A1NPC1RAB9A | |
| SCHEMBL15481289 | 0.83 | LMNA (0.45) | LMNATSHRALDH1A1NPC1RAB9A | |
| SCHEMBL15482109 | 0.82 | LMNA (0.55) | LMNATSHRALDH1A1NPC1RAB9A | |
| SCHEMBL9816400 | 0.82 | LMNA (0.55) | LMNATSHRALDH1A1NPC1RAB9A | |
| SCHEMBL1473473 | 0.82 | TP53 (0.46) | LMNATSHRALDH1A1NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7615656-B2 | Cycloaliphatic polyepoxy compounds and preparation thereof | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2009-11-10 | — | — | US | disclosed |
| US-7429622-B2 | Active ray curable ink-jet composition, image forming method using the same, ink-jet recording apparatus, and triarylsulfonium salt compound | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2008-09-30 | — | — | US | disclosed |
| US-20080004425-A1 | Cycloaliphatic polyepoxy compounds and prepartation thereof | DAICEL CHEMICAL INDUSTRIES, LTD. | 2008-01-03 | — | — | US | disclosed |
| EP-1873149-A1 | Cycloaliphatic polyepoxy compounds and preparation thereof | Daicel Chemical Industries, Ltd. (JP) | 2008-01-02 | — | — | EP | disclosed |
| US-7244473-B2 | Active ray curable ink-jet composition, image forming method using the same, ink-jet recording apparatus, and triarylsulfonium salt compound | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2007-07-17 | — | — | US | disclosed |
| US-20070054974-A1 | Active ray curable ink-jet composition, image forming method using the same, ink-jet recording apparatus, and triarylsulfonium salt compound | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2007-03-08 | — | — | US | disclosed |
| US-20060264529-A1 | ACTIVE ENERGY RAY CURABLE COMPOSITION | KONICA MINOLTA HOLDINGS, INC. (JP) | 2006-11-23 | — | — | US | disclosed |
| US-20040244641-A1 | Active ray curable ink-jet composition, image forming method using the same, ink-jet recording apparatus, and triarylsulfonium salt compound | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2004-12-09 | — | — | US | disclosed |
| US-20040167315-A1 | Active energy ray curable composition | KONICA MINOLTA HOLDINGS, INC. (JP) | 2004-08-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040244641-A1 | Active ray curable ink-jet composition, image forming method using the same, ink-jet recording apparatus, and triarylsulfonium salt compound | JAK1, INO80, ROR1 | LMNA 4608/4885TSHR 3739/4885ALDH1A1 3331/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.